T. R. J. Evans

A Phase I Pharmacokinetic and Pharmacodynamic Study of TKI258, an Oral, Multitargeted Receptor Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors

Debashis Sarker, R. Molife, T. R. J. Evans et al. · Clinical Cancer Research · 2008 · 137 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Septic arthritis of the knee following anterior cruciate ligament reconstruction: results of a survey of sports medicine fellowship directors

MJ Matava, T. R. J. Evans, RW Wright et al. · Arthroscopy The Journal of Arthroscopic and Related Surgery · 1998 · 114 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +16

Pharmacokinetic and pharmacodynamic properties of an oral formulation of the histone deacetylase inhibitor Belinostat (PXD101)

Nicola Steele, Jane A. Plumb, Laura Vidal et al. · Cancer Chemotherapy and Pharmacology · 2010 · 55 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Phase I study of ONO-4007, a synthetic analogue of the lipid A moiety of bacterial lipopolysaccharide.

Johann S. de Bono, Angus Dalgleish, J Carmichael et al. · PubMed · 2000 · 49 citations

Medicine, Immunology, Pharmacology +17

Phase I dose-escalation study of the SRC and multi-kinase inhibitor BMS-354825 in patients (pts) with GIST and other solid tumors

T. R. J. Evans, J. A. Morgan, Annick D. Van den Abbeele et al. · Journal of Clinical Oncology · 2005 · 31 citations

Medicine, Oncology, Pharmacology +17